Home Hospital for Lymphoma
NCT04423848 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2022-10-28
Summary
The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.
Conditions
Interventions
- OTHER
-
Home Hospital for Lymphoma
Remote monitoring and home-based care designed for hospitalized patients with lymphoma
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Areej El-Jawahri, MD · Massachusetts General Hospital
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2021-01-01
- Completion
- 2021-01-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma
NCT00141700 ·Status: TERMINATED ·Phase: PHASE2
-
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
NCT00278408 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclophosphamide and Alemtuzumab In Lymphoma
NCT03132584 ·Status: TERMINATED ·Phase: PHASE1
-
Radiation Post-CAR T in Refractory Lymphoma
NCT04473937 ·Status: TERMINATED ·Phase: NA
-
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT01466868 ·Status: TERMINATED ·Phase: PHASE2
-
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
NCT04982471 ·Status: TERMINATED
-
S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
NCT00005089 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).
NCT00301314 ·Status: COMPLETED
-
This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas
NCT01279772 ·Status: TERMINATED
-
Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
NCT00645359 ·Status: TERMINATED
-
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
NCT01476787 ·Status: COMPLETED ·Phase: PHASE3
-
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
NCT01148173 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT00428142 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life Among Survivors of Hodgkin Lymphoma
NCT00598728 ·Status: COMPLETED
-
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
NCT01228461 ·Status: COMPLETED
-
Navigating the Clinical Research Process for Lymphoma
NCT06070246 ·Status: NOT_YET_RECRUITING
-
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
NCT00186394 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
NCT01729104 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)
NCT01476085 ·Status: TERMINATED ·Phase: PHASE1
-
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00278421 ·Status: COMPLETED ·Phase: PHASE3
-
Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma
NCT04231734 ·Status: WITHDRAWN ·Phase: NA
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
NCT00003204 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
NCT00482053 ·Status: TERMINATED ·Phase: PHASE2
-
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
NCT01761682 ·Status: TERMINATED